NCT05355701 2026-06-05A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.PfizerPhase 1 Recruiting267 enrolled
NCT07426757 2026-06-01An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced CancersPfizerPhase 1 Recruiting120 enrolled